{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:06:32Z","timestamp":1791331592901,"version":"4.3.1"},"reference-count":54,"publisher":"Institute of Physiology of the Czech Academy of Sciences","funder":[{"DOI":"10.13039\/100007543","name":"Grantov\u00e1 Agentura, Univerzita Karlova","doi-asserted-by":"publisher","award":["1276818"],"award-info":[{"award-number":["1276818"]}],"id":[{"id":"10.13039\/100007543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007543","name":"Grantov\u00e1 Agentura, Univerzita Karlova","doi-asserted-by":"publisher","award":["364218"],"award-info":[{"award-number":["364218"]}],"id":[{"id":"10.13039\/100007543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiol Res"],"published-print":{"date-parts":[[2020,6,30]]},"abstract":"<jats:p>A close interaction between the virus SARS-CoV-2 and the immune system of an individual results in a diverse clinical manifestation of the COVID-19 disease. While adaptive immune responses are essential for SARS-CoV-2 virus clearance, the innate immune cells, such as macrophages, may contribute, in some cases, to the disease progression. Macrophages have shown a significant production of IL-6, suggesting they may contribute to the excessive inflammation in COVID-19 disease. Macrophage Activation Syndrome may further explain the high serum levels of CRP, which are normally lacking in viral infections. In adaptive immune responses, it has been revealed that cytotoxic CD8+ T cells exhibit functional exhaustion patterns, such as the expression of NKG2A, PD-1, and TIM-3. Since SARS-CoV-2 restrains antigen presentation by downregulating MHC class I and II molecules and, therefore, inhibits the T cell-mediated immune responses, humoral immune responses also play a substantial role. Specific IgA response appears to be stronger and more persistent than the IgM response. Moreover, IgM and IgG antibodies show similar dynamics in COVID-19 disease.<\/jats:p>","DOI":"10.33549\/physiolres.934492","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T11:48:53Z","timestamp":1596196133000},"page":"379-388","source":"Crossref","is-referenced-by-count":261,"title":["COVID-19 and the Immune System"],"prefix":"10.33549","author":[{"given":"J","family":"PACES","sequence":"first","affiliation":[{"name":"Laboratory of Cell Immunology, Faculty of Science, Charles University, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"STRIZOVA","sequence":"additional","affiliation":[{"name":"Department of Immunology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"SMRZ","sequence":"additional","affiliation":[{"name":"Department of Immunology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"CERNY","sequence":"additional","affiliation":[{"name":"Laboratory of Cell Immunology, Faculty of Science, Charles University, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"19169","published-online":{"date-parts":[[2020,6,30]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"BARTON LM, DUVAL EJ, STROBERG E, GHOSH S, MUKHOPADHYAY S: COVID-19 autopsies, Oklahoma, USA. Am J Clin Pathol 153: 725-733, 2020. https:\/\/doi.org\/10.1093\/ajcp\/aqaa062","DOI":"10.1093\/ajcp\/aqaa062"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"CAO X: COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol 20: 269-270, 2020. https:\/\/doi.org\/10.1038\/s41577-020-0308-3","DOI":"10.1038\/s41577-020-0308-3"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"CHAN JF, KOK KH, ZHU Z, CHU H, TO KK, YUAN S, YUEN KY: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect 9: 221-236, 2020. https:\/\/doi.org\/10.1080\/22221751.2020.1719902","DOI":"10.1080\/22221751.2020.1719902"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"CHEN G, WU D, GUO W, CAO Y, HUANG D, WANG H, WANG T, ZHANG X, CHEN H, YU H, ZHANG X, ZHANG M, WU S, SONG J, CHEN T, HAN M, LI S, LUO X, ZHAO J, NING Q: Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 130: 2620-2629, 2020. https:\/\/doi.org\/10.1172\/JCI137244","DOI":"10.1101\/2020.02.16.20023903"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"CLEMENTZ MA, CHEN Z, BANACH BS, WANG Y, SUN L, RATIA K, BAEZ-SANTOS YM, WANG J, TAKAYAMA J, GHOSH AK, LI K, MESECAR AD, BAKER SC: Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. J Virol 84: 4619-4629, 2010. https:\/\/doi.org\/10.1128\/JVI.02406-09","DOI":"10.1128\/jvi.02406-09"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"DONG X, CAO YY, LU XX, ZHANG JJ, DU H, YAN YQ, AKDIS CA, GAO YD: Eleven faces of coronavirus disease 2019. Allergy: 10.1111\/all.14289, 2020. https:\/\/doi.org\/10.1111\/all.14289","DOI":"10.1111\/all.14289"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"FRIEMAN M, HEISE M, BARIC R: SARS coronavirus and innate immunity. Virus Res 133: 101-112, 2008. https:\/\/doi.org\/10.1016\/j.virusres.2007.03.015","DOI":"10.1016\/j.virusres.2007.03.015"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"GAO M, YANG L, CHEN X, DENG Y, YANG S, XU H, CHEN Z, GAO X: A study on infectivity of asymptomatic SARS-CoV-2 carriers. Respir Med 169: 106026, 2020. https:\/\/doi.org\/10.1016\/j.rmed.2020.106026","DOI":"10.1016\/j.rmed.2020.106026"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"GRANT WB, LAHORE H, MCDONNELL SL, BAGGERLY CA, FRENCH CB, ALIANO JL, BHATTOA HP: Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients 12: 988, 2020. https:\/\/doi.org\/10.3390\/nu12040988","DOI":"10.3390\/nu12040988"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"GRIFONI A, WEISKOPF D, RAMIREZ SI, MATEUS J, DAN JM, MODERBACHER CR, RAWLINGS SA, SUTHERLAND A, PREMKUMAR L, JADI RS, MARRAMA D, DE SILVA AM, FRAZIER A, CARLIN A, GREENBAUM JA, PETERS B, KRAMMER F, SMITH DM, CROTTY S, SETTE A: Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181: 1-13, 2020. https:\/\/doi.org\/10.1016\/j.cell.2020.05.015","DOI":"10.1016\/j.cell.2020.05.015"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"GU J, GONG E, ZHANG B, ZHENG J, GAO Z, ZHONG Y, ZOU W, ZHAN J, WANG S, XIE Z, ZHUANG H, WU B, ZHONG H, SHAO H, FANG W, GAO D, PEI F, LI X, HE Z, XU D, SHI X, ANDERSON VM, LEONG AS. Multiple organ infection and the pathogenesis of SARS. J Exp Med 202: 415-424, 2005. https:\/\/doi.org\/10.1084\/jem.20050828","DOI":"10.1084\/jem.20050828"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"GUO L, REN L, YANG S, XIAO M, CHANG D, YANG F, DELA CRUZ CS, WANG Y, WU C, XIAO Y, ZHANG L, HAN L, DANG S, XU Y, YANG Q, XU S, ZHU H, XU Y, JIN Q, SHARMA L, WANG L, WANG J: Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis: ciaa310, 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa310","DOI":"10.1093\/cid\/ciaa310"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"HACKBART M, DENG X, BAKER SC: Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors. Proc Natl Acad Sci U S A 117: 8094-8103, 2020. https:\/\/doi.org\/10.1073\/pnas.1921485117","DOI":"10.1073\/pnas.1921485117"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"HOFFMANN M, KLEINE-WEBER H, SCHROEDER S, KR\u00dcGER N, HERRLER T, ERICHSEN S, SCHIERGENS TS, HERRLER G, WU NH, NITSCHE A, M\u00dcLLER MA, DROSTEN C, P\u00d6HLMANN S: SARS-CoV-2 cell entry 384 depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease 385 inhibitor. Cell 181: 271-280.e8, 2020. https:\/\/doi.org\/386 10.1016\/j.cell.2020.02.052","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"HUANG C, WANG Y, LI X, REN L, ZHAO J, HU Y, ZHANG L, FAN G, XU J, GU X, CHENG Z, YU T, XIA J, WEI Y, WU W, XIE X, YIN W, LI H, LIU M, XIAO Y, GAO H, GUO L, XIE J, WANG G, JIANG R, GAO Z, JIN Q, WANG J, CAO B: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395: 497-506, 2020. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","DOI":"10.1016\/s0140-6736(20)30183-5"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"JAILLON S, BERTHENET K, GARLANDA C: Sexual dimorphism in innate immunity. Clin Rev Allergy Immunol 56: 308-321, 2019. https:\/\/doi.org\/10.1007\/s12016-017-8648-x","DOI":"10.1007\/s12016-017-8648-x"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"JASON JR: Pathogenesis of COVID-19 from a cell biology perspective. Eur Respir J 55: 2000607, 2020. https:\/\/doi.org\/10.1183\/13993003.00607-2020","DOI":"10.1183\/13993003.00607-2020"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"LIU J, LI S, LIU J, LIANG B, WANG X, WANG H, LI W, TONG Q, YI J, ZHAO L, XIONG L, GUO C, TIAN J, LUO J, YAO J, PANG R, SHEN H, PENG C, LIU T, ZHANG Q, WU J, XU L, LU S, WANG B, WENG Z, HAN C, ZHU H, ZHOU R, ZHOU H, CHEN X, YE P, ZHU B, WANG L, ZHOU W, HE S, HE Y, JIE S, WEI P, ZHANG J, LU Y, WANG W, ZHANG L, LI L, ZHOU F, WANG J, DITTMER U, LU M, HU Y, YANG D, ZHENG X: Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine 55: 102763, 2020. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102763","DOI":"10.1016\/j.ebiom.2020.102763"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"LIU W, FONTANET A, ZHANG PH, ZHAN L, XIN ZT, BARIL L, TANG F, LV H, CAO WC: Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome. J Infect Dis 193: 792-795, 2006. https:\/\/doi.org\/10.1086\/500469","DOI":"10.1086\/500469"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"MCGONAGLE D, SHARIF K, O'REGAN A, BRIDGEWOOD C: The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev 19: 102537, 2020. https:\/\/doi.org\/10.1016\/j.autrev.2020.102537","DOI":"10.1016\/j.autrev.2020.102537"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"MOON C: Fighting COVID-19 exhausts T cells. Nat Rev Immunol 20: 277, 2020. https:\/\/doi.org\/10.1038\/s41577-020-0304-7","DOI":"10.1038\/s41577-020-0304-7"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"OKBA NMA, M\u00dcLLER MA, LI W, WANG C, GEURTSVANKESSEL CH, CORMAN VM, LAMERS MM, SIKKEMA RS, BRUIN E, CHANDLER FD, YAZDANPANAH Y, HINGRAT QL, DESCAMPS N, HOUHOU-FIDOUH N, REUSKEN CBEM, BOSCH BJ, DROSTEN C, KOOPMANS MPG, HAAGMANS BL: Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019 patients. Emerg Infect Dis 26: 2020. https:\/\/doi.org\/10.3201\/eid2607.200841","DOI":"10.3201\/eid2607.200841"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"OKABAYASHI T, KARIWA H, YOKOTA S, IKI S, INDOH T, YOKOSAWA N, TAKASHIMA I, TSUTSUMI H, FUJII N: Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections. J Med Virol 78: 417-424, 2006. https:\/\/doi.org\/10.1002\/jmv.20556","DOI":"10.1002\/jmv.20556"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"OPAL SM, GIRARD TD, ELY EW: The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis 41 (Suppl 7): S504-S512. 2005. https:\/\/doi.org\/10.1086\/432007","DOI":"10.1086\/432007"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"PADOAN A, SCIACOVELLI L, BASSO D, NEGRINI D, ZUIN S, COSMA C, FAGGIAN D, MATRICARDI P, PLEBANI M: IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study. Clin Chim Acta 507: 164-166, 2020. https:\/\/doi.org\/10.1016\/j.cca.2020.04.026","DOI":"10.1016\/j.cca.2020.04.026"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"PARK MD: Macrophages: a Trojan horse in COVID-19? Nat Rev Immunol 20: 351, 2020. https:\/\/doi.org\/10.1038\/s41577-020-0317-2","DOI":"10.1038\/s41577-020-0317-2"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"PROMPETCHARA E, KETLOY C, PALAGA T: Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol: 38: 1-9, 2020. https:\/\/doi.org\/10.12932\/AP-200220-0772","DOI":"10.12932\/ap-200220-0772"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"RAJENDRAN K, KRISHNASAMY N, RANGARAJAN J, RATHINAM J, NATARAJAN M, RAMACHANDRAN A: Convalescent plasma transfusion for the treatment of COVID-19: Systematic review. J Med Virol: 10.1002\/jmv.25961, 2020. https:\/\/doi.org\/10.1002\/jmv.25961","DOI":"10.1002\/jmv.25961"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"RIZZO P, VIECELI DALLA SEGA F, FORTINI F, MARRACINO L, RAPEZZI C, FERRARI R: COVID-19 in the heart and the lungs: could we \"Notch\" the inflammatory storm? Basic Res Cardiol 115: 31, 2020 https:\/\/doi.org\/10.1007\/s00395-020-0791-5","DOI":"10.1007\/s00395-020-0791-5"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"RUSSELL B, MOSS C, GEORGE G, SANTAOLALLA A, COPE A, PAPA S, VAN HEMELRIJCK M: Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence. Ecancermedicalscience 14: 1022, 2020. https:\/\/doi.org\/10.3332\/ecancer.2020.1022","DOI":"10.3332\/ecancer.2020.1022"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"SHAKOORY B, CARCILLO JA, CHATHAM WW, AMDUR RL, ZHAO H, DINARELLO CA, CRON RQ, OPAL SM: Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III Trial. Crit Care Med 44: 275-281, 2016. https:\/\/doi.org\/10.1097\/CCM.0000000000001402","DOI":"10.1097\/ccm.0000000000001402"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"SHI Y, WANG Y, SHAO C, HUANG J, GAN J, HUANG X, BUCCI E, PIACENTINI M, IPPOLITO G, MELINO G: COVID-19 infection: the perspectives on immune responses. Cell Death Differ 27: 1451-1454, 2020. https:\/\/doi.org\/10.1038\/s41418-020-0530-3","DOI":"10.1038\/s41418-020-0530-3"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"SIU KL, KOK KH, NG MH, POON VK, YUEN KY, ZHENG BJ, JIN DY: Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1\/IKKepsilon complex. J Biol Chem 284: 16202-16209 2009. https:\/\/doi.org\/10.1074\/jbc.M109.008227","DOI":"10.1074\/jbc.m109.008227"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"SMITS SL, DE LANG A, VAN DEN BRAND JM, LEIJTEN LM, VAN IJCKEN WF, EIJKEMANS MJ, VAN AMERONGEN G, KUIKEN T, ANDEWEG AC, OSTERHAUS AD, HAAGMANS BL: Exacerbated innate host response to SARS-CoV in aged non-human primates. PLoS Pathog 6: e1000756, 2010. https:\/\/doi.org\/10.1371\/journal.ppat.1000756","DOI":"10.1371\/journal.ppat.1000756"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"THEVARAJAN I, NGUYEN THO, KOUTSAKOS M, DRUCE J, CALY L, VAN DE SANDT CE, JIA X, NICHOLSON S, CATTON M, COWIE B, TONG SYC, LEWIN SR, KEDZIERSKA K: Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med 26: 453-455, 2020. https:\/\/doi.org\/10.1038\/s41591-020-0819-2","DOI":"10.1038\/s41591-020-0819-2"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"TO KK, TSANG OT, LEUNG WS, TAM AR, WU TC, LUNG DC, YIP CC, CAI JP, CHAN JM, CHIK TS, LAU DP, CHOI CY, CHEN LL, CHAN WM, CHAN KH, IP JD, NG AC, POON RW, LUO CT, CHENG VC, CHAN JF, HUNG IF, CHEN Z, CHEN H, YUEN KY: Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis 20: 565-574, 2020. https:\/\/doi.org\/10.1016\/S1473-3099(20)30196-1","DOI":"10.1016\/s1473-3099(20)30196-1"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"TOTURA AL, WHITMORE A, AGNIHOTHRAM S, SCH\u00c4FER A, KATZE MG, HEISE MT, BARIC RS: Toll-like receptor 3 signaling via TRIF Contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection. mBio 6: e00638-15, 2015. https:\/\/doi.org\/10.1128\/mBio.00638-15","DOI":"10.1128\/mbio.00638-15"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"WANG C, LI W, DRABEK D, OKBA NMA, VAN HAPEREN R, OSTERHAUS ADME, VAN KUPPEVELD FJM, HAAGMANS BL, GROSVELD F, BOSCH BJ: A human monoclonal antibody blocking SARS-CoV-2 infection. Nat Commun 11: 2251, 2020. https:\/\/doi.org\/10.1038\/s41467-020-16256-y","DOI":"10.1101\/2020.03.11.987958"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"WANG Y, LIU L: The membrane protein of severe acute respiratory syndrome coronavirus functions as a novel cytosolic pathogen-associated molecular pattern to promote beta interferon induction via a toll-like-receptor-related TRAF3-independent mechanism. mBio 7: e01872-15, 2016. https:\/\/doi.org\/10.1128\/mBio.01872-15","DOI":"10.1128\/mbio.01872-15"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"WESTON S, FRIEMAN MB: COVID-19: Knowns, unknowns, and questions. mSphere 5: e00203-20, 2020. https:\/\/doi.org\/10.1128\/mSphere.00203-20","DOI":"10.1128\/msphere.00203-20"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"WU LP, WANG NC, CHANG YH, TIAN XY, NA DY, ZHANG LY, ZHENG L, LAN T, WANG LF, LIANG GD. Duration of antibody responses after severe acute respiratory syndrome. Emerg Infect Dis 13: 1562-1564, 2007. https:\/\/doi.org\/10.3201\/eid1310.070576","DOI":"10.3201\/eid1310.070576"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"XU Z, SHI L, WANG Y, ZHANG J, HUANG L, ZHANG C, LIU S, ZHAO P, LIU H, ZHU L, TAI Y, BAI C, GAO T, SONG J, XIA P, DONG J, ZHAO J, WANG FS: Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 8: 420-422, 2020. https:\/\/doi.org\/10.1016\/S2213-2600(20)30076-X","DOI":"10.1016\/s2213-2600(20)30076-x"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"YAO XH, LI TY, HE ZC, PING YF, LIU HW, YU SC, MOU HM, WANG LH, ZHANG HR, FU WJ, LUO T, LIU F, CHEN C, XIAO HL, GUO HT, LIN S, XIANG DF, SHI Y, LI QR, HUANG X, CUI Y, LI XZ, TANG W, PAN PF, HUANG XQ, DING YQ, BIAN XW: A pathological report of three COVID-19 cases by minimally invasive autopsies. (In Chinese) Zhonghua Bing Li Xue Za Zhi 49: 411-417, 2020. https:\/\/doi.org\/10.3760\/cma.j.cn112151-20200312-00193","DOI":"10.1101\/2020.03.18.20038018"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"YU N, LI W, KANG Q, XIONG Z, WANG S, LIN X, LIU Y, XIAO J, LIU H, DENG D, CHEN S, ZENG W, FENG L, WU J: Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study. Lancet Infect Dis 20: 559-564, 2020. https:\/\/doi.org\/10.1016\/S1473-3099(20)30176-6","DOI":"10.1016\/s1473-3099(20)30176-6"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"YU X, YANG R: COVID-19 transmission through asymptomatic carriers is a challenge to containment. Influenza Other Respir Viruses: 10.1111\/irv.12743, 2020. https:\/\/doi.org\/10.1111\/irv.12743","DOI":"10.1111\/irv.12743"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"ZENG G, XIE SY, LI Q: Infectivity of severe acute respiratory syndrome during its incubation period. Biomed Environ Sci 22: 502-510, 2009. https:\/\/doi.org\/10.1016\/S0895-3988(10)60008-6","DOI":"10.1016\/s0895-3988(10)60008-6"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"ZHANG W, ZHAO Y, ZHANG F, WANG Q, LI T, LIU Z, WANG J, QIN Y, ZHANG X, YAN X, ZENG X, ZHANG S: The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China. Clin Immunol 214: 108393, 2020. https:\/\/doi.org\/10.1016\/j.clim.2020.108393","DOI":"10.1016\/j.clim.2020.108393"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"ZHAO J, YUAN Q, WANG H, LIU W, LIAO X, SU Y, WANG X, YUAN J, LI T, LI J, QIAN S, HONG C, WANG F, LIU Y, WANG Z, HE Q, LI Z, HE B, ZHANG T, FU Y, GE S, LIU L, ZHANG J, XIA N, ZHANG Z: Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis: ciaa344, 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa344","DOI":"10.1093\/cid\/ciaa344"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"ZHENG M, GAO Y, WANG G, SONG G, LIU S, SUN D, XU Y, TIAN Z: Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol 17: 533-535, 2020. https:\/\/doi.org\/10.1038\/s41423-020-0402-2","DOI":"10.1038\/s41423-020-0402-2"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"ZHOU F, YU T, DU R, FAN G, LIU Y, LIU Z, XIANG J, WANG Y, SONG B, GU X, GUAN L, WEI Y, LI H, WU X, XU J, TU S, ZHANG Y, CHEN H, CAO B: Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395: 1054-1062, 2020. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3","DOI":"10.1016\/s0140-6736(20)30566-3"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"ZHOU P, YANG XL, WANG XG, HU B, ZHANG L, ZHANG W, SI HR, ZHU Y, LI B, HUANG CL, CHEN HD, CHEN J, LUO Y, GUO H, JIANG RD, LIU MQ, CHEN Y, SHEN XR, WANG X, ZHENG XS, ZHAO K, CHEN QJ, DENG F, LIU LL, YAN B, ZHAN FX, WANG YY, XIAO GF, SHI ZL: A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579: 270-273, 2020. https:\/\/doi.org\/101038\/s41586-020-2012-7","DOI":"10.1038\/s41586-020-2012-7"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"ZHU N, ZHANG D, WANG W, LI X, YANG B, SONG J, ZHAO X, HUANG B, SHI W, LU R, NIU P, ZHAN F, MA X, WANG D, XU W, WU G, GAO GF, TAN W: A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382: 727-733, 2020. https:\/\/doi.org\/10.1056\/NEJMoa2001017","DOI":"10.1056\/nejmoa2001017"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"ZINKERNAGEL RM: On natural and artificial vaccinations. Annu Rev Immunol 21: 515-546, 2003. https:\/\/doi.org\/10.1146\/annurev.immunol.21.120601.141045","DOI":"10.1146\/annurev.immunol.21.120601.141045"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Z\u00dcST R, CERVANTES-BARRAGAN L, HABJAN M, MAIER R, NEUMAN B W, ZIEBUHR J, SZRETTER KJ, BAKER S C, BARCHET W, DIAMOND MS, SIDDELL S G, LUDEWIG B, THIEL V: Ribose 2\u2019-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5, 2011. Nat Immunol 12: 137-143, 2011. https:\/\/doi.org\/10.1038\/ni.1979","DOI":"10.1038\/ni.1979"}],"container-title":["Physiological Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T11:48:58Z","timestamp":1596196138000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomed.cas.cz\/physiolres\/pdf\/2020\/69_379.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,30]]},"references-count":54,"URL":"https:\/\/doi.org\/10.33549\/physiolres.934492","relation":{},"ISSN":["1802-9973","0862-8408"],"issn-type":[{"value":"1802-9973","type":"electronic"},{"value":"0862-8408","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,30]]}}}